Dchs2, or dachsous cadherin-related 2, plays a crucial role in various cellular processes, particularly in the context of nephron development and cell-cell junction formation. The protein is predicted to enable calcium ion binding activity, positioning it as a key player in mediating interactions between cells. Its influence extends to the regulation of condensed mesenchymal cell proliferation, a pivotal process in nephrogenesis. Dchs2 is expressed in tissues such as the brain, pharyngo-tympanic tube, and spinal cord, underscoring its importance in diverse physiological contexts. The function of Dchs2 hinges on its ability to bind calcium ions, thereby participating in the formation of stable cell-cell junctions and orchestrating mesenchymal cell proliferation during nephron development. Disruptions to this intricate process can have profound consequences on tissue architecture and organogenesis. The inhibition of Dchs2 involves a multifaceted approach, leveraging the modulation of interconnected signaling pathways and cellular processes.
Several chemicals presented here exert their inhibitory effects on Dchs2 through indirect means. For instance, compounds targeting TGF-β receptors disrupt downstream events related to Dchs2, interfering with its role in cell-cell junction formation and mesenchymal cell proliferation. Similarly, inhibitors of PI3K, MEK, and AMPK, among others, influence signaling cascades that intricately intersect with Dchs2's functions, leading to an impediment in its activity. These mechanisms collectively emphasize the complexity of cellular regulation and the need for a nuanced understanding of the interconnected pathways governing the actions of Dchs2. In essence, the inhibition of Dchs2 involves perturbing the intricate balance of cellular processes critical for its normal functioning. The presented chemicals act as strategic modulators, influencing pathways both directly and indirectly linked to Dchs2, thereby disrupting its calcium ion binding activity and subsequent cellular functions. Understanding these intricate interactions is essential for unraveling the regulatory networks governing nephron development and cell-cell interactions, providing valuable insights for further exploration in the realm of cellular and developmental biology.
SEE ALSO...
Items 11 to 12 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB-203580, a p38 MAPK inhibitor, indirectly influences Dchs2 by disrupting the p38 MAPK signaling pathway. This interference leads to downstream effects that negatively impact Dchs2's role in cell-cell junction and mesenchymal cell proliferation during nephron development. | ||||||
A-769662 | 844499-71-4 | sc-203790 sc-203790A sc-203790B sc-203790C sc-203790D | 10 mg 50 mg 100 mg 500 mg 1 g | $184.00 $741.00 $1076.00 $3417.00 $5304.00 | 23 | |
A769662, an AMPK activator, indirectly influences Dchs2 by modulating cellular energy balance. By activating AMPK, A769662 impacts downstream events that negatively impact Dchs2's role in cell-cell junction and mesenchymal cell proliferation during nephron development. | ||||||